Fall 2026 Co-Op – Translational Development, Neuroscience TRC at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Familiarity with the basic principles of cell biology and/or neuroscience
Strong organizational and communication skills
Prior experience with immunoassays, qPCR, cell culture, and in vivo sample preparation is preferred
Experience with data analysis software (e.g., Excel, GraphPad Prism) is preferred
Authorized to work in the US both at the time of hire and for the duration of employment

Responsibilities

Develop immunoassay protocols to examine select proteins in human, NHP, and mouse tissues and biofluids
Develop cell based readouts for disease relevant pathways
Document experimental results
Generate an SOP for methods established

Skills

Key technologies and capabilities for this role

immunoassaysqPCRcell-based assayscell culturecell biologyneuroscience

Questions & Answers

Common questions about this position

What is the hourly pay rate for this co-op position?

The starting hourly compensation is within the range of $27.00 to $29.00/hr, with final compensation determined by factors like experience, skills, and location.

Is this co-op position remote or on-site?

This information is not specified in the job description.

What skills and experience are required for this role?

Familiarity with basic principles of cell biology and/or neuroscience is required, along with strong organizational and communication skills. Prior experience with immunoassays, qPCR, cell culture, in vivo sample preparation, and data analysis software like Excel or GraphPad Prism is preferred.

What is the company culture like at Bristol Myers Squibb?

The culture emphasizes challenging, meaningful, and life-changing work that transforms patients' lives and careers, with opportunities to grow alongside high-achieving teams and a focus on balance and flexibility.

What makes a strong candidate for this co-op?

A strong candidate will have familiarity with cell biology or neuroscience principles, strong organizational and communication skills, and preferably prior hands-on experience with immunoassays, qPCR, cell culture, in vivo samples, and data analysis tools.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free